191 related articles for article (PubMed ID: 11002408)
1. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology.
Femiano F; Gombos F; Scully C; Busciolano M; De Luca P
Oral Dis; 2000 Sep; 6(5):274-7. PubMed ID: 11002408
[TBL] [Abstract][Full Text] [Related]
2. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies.
Femiano F
Minerva Stomatol; 2002 Sep; 51(9):405-9. PubMed ID: 12473978
[TBL] [Abstract][Full Text] [Related]
3. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.
Femiano F; Scully C
J Oral Pathol Med; 2002 May; 31(5):267-9. PubMed ID: 12110042
[TBL] [Abstract][Full Text] [Related]
4. Burning mouth syndrome: the efficacy of lipoic acid on subgroups.
Femiano F; Gombos F; Scully C
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):676-8. PubMed ID: 15482293
[TBL] [Abstract][Full Text] [Related]
5. Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial.
Palacios-Sánchez B; Moreno-López LA; Cerero-Lapiedra R; Llamas-Martínez S; Esparza-Gómez G
Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e435-40. PubMed ID: 26034927
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study.
López-Jornet P; Camacho-Alonso F; Leon-Espinosa S
J Oral Rehabil; 2009 Jan; 36(1):52-7. PubMed ID: 18976257
[TBL] [Abstract][Full Text] [Related]
7. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial.
López-D'alessandro E; Escovich L
Med Oral Patol Oral Cir Bucal; 2011 Aug; 16(5):e635-40. PubMed ID: 20711135
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic dysgeusia; an open trial of alpha lipoic acid (ALA) therapy.
Femiano F; Scully C; Gombos F
Int J Oral Maxillofac Surg; 2002 Dec; 31(6):625-8. PubMed ID: 12521319
[TBL] [Abstract][Full Text] [Related]
9. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
[TBL] [Abstract][Full Text] [Related]
10. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial.
Cavalcanti DR; da Silveira FR
J Oral Pathol Med; 2009 Mar; 38(3):254-61. PubMed ID: 19175713
[TBL] [Abstract][Full Text] [Related]
11. Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy.
Femiano F; Gombos F; Scully C
Med Oral; 2004; 9(1):8-13. PubMed ID: 14704612
[TBL] [Abstract][Full Text] [Related]
12. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study.
Carbone M; Pentenero M; Carrozzo M; Ippolito A; Gandolfo S
Eur J Pain; 2009 May; 13(5):492-6. PubMed ID: 18675569
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of laser therapy and alpha-lipoic acid for the treatment of burning mouth syndrome: a randomized clinical trial.
Barbosa NG; Gonzaga AKG; de Sena Fernandes LL; da Fonseca AG; Queiroz SIML; Lemos TMAM; da Silveira ÉJD; de Medeiros AMC
Lasers Med Sci; 2018 Aug; 33(6):1255-1262. PubMed ID: 29502160
[TBL] [Abstract][Full Text] [Related]
14. Alpha-lipoic acid treatment of 31 patients with sore, burning mouth.
Steele JC; Bruce AJ; Drage LA; Rogers RS
Oral Dis; 2008 Sep; 14(6):529-32. PubMed ID: 18266840
[TBL] [Abstract][Full Text] [Related]
15. The efficiency of alpha-lipoic acid in the treatment of burning mouth syndrome: a systematic review.
Alqahtani SS
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6585-6591. PubMed ID: 34787861
[TBL] [Abstract][Full Text] [Related]
16. Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature.
de Moraes M; do Amaral Bezerra BA; da Rocha Neto PC; de Oliveira Soares AC; Pinto LP; de Lisboa Lopes Costa A
J Oral Pathol Med; 2012 Apr; 41(4):281-7. PubMed ID: 22092585
[TBL] [Abstract][Full Text] [Related]
17. Burning mouth syndrome: a systematic review of treatments.
Liu YF; Kim Y; Yoo T; Han P; Inman JC
Oral Dis; 2018 Apr; 24(3):325-334. PubMed ID: 28247977
[TBL] [Abstract][Full Text] [Related]
18. Different therapeutic strategies for burning mouth syndrome: preliminary data.
Marino R; Torretta S; Capaccio P; Pignataro L; Spadari F
J Oral Pathol Med; 2010 Sep; 39(8):611-6. PubMed ID: 20701667
[TBL] [Abstract][Full Text] [Related]
19. [Burning mouth syndrome and alpha-lipoic acid].
Cervigón González I; Torres LM; Palomo A
Actas Dermosifiliogr; 2009 Mar; 100(2):154-5. PubMed ID: 19445885
[No Abstract] [Full Text] [Related]
20. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
